MitoChem Therapeutics, Inc.
PrivateLast Round
Grant
Sep 21, 2023
Total Funding Raised
$2.63M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
MitoChem Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in Charleston, South Carolina. Its latest recorded funding round was a Grant round in September 2023.
MitoChem Therapeutics, Inc. is a biotechnology company that develops small molecule therapeutics targeting mitochondrial dysfunction to treat neurodegenerative and retinal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MitoChem Therapeutics, Inc. Comparables
Compare MitoChem Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mitochon Pharmaceuticals | 86% | |
| NRG Therapeutics | 83% | |
| Evvia Therapeutics | 81% |
For institutional investors. Book with your work email.
MitoChem Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 21, 2023 | ||||
| Seed | Aug 11, 2022 |
For institutional investors. Book with your work email.
MitoChem Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SC Launch | Grant, Seed |
| Foundation Fighting Blindness | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 133% MoM, reaching 1.5K.
- May 4, 2025
Monthly visitors grew 1008% MoM, from 89 to 986.
For institutional investors. Book with your work email.
MitoChem Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MitoChem Therapeutics, Inc.'s valuation, stock price, and market status.
Is MitoChem Therapeutics, Inc. a public or private company?
MitoChem Therapeutics, Inc. is a private company.
What is the current stock price of MitoChem Therapeutics, Inc.?
MitoChem Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks MitoChem Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MitoChem Therapeutics, Inc. worth (valuation)?
Valuation information for MitoChem Therapeutics, Inc. is not publicly available.
Can I buy MitoChem Therapeutics, Inc. stock?
MitoChem Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MitoChem Therapeutics, Inc.'s last funding round?
MitoChem Therapeutics, Inc.'s most recent funding round was Grant on September 21, 2023.
Who are the main investors in MitoChem Therapeutics, Inc.?
Key investors in MitoChem Therapeutics, Inc. include SC Launch, Foundation Fighting Blindness.
Will MitoChem Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for MitoChem Therapeutics, Inc..
How can I track MitoChem Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in MitoChem Therapeutics, Inc.'s shares on secondary markets.